Keyphrases
Patients with Cardiovascular Diseases
100%
Thrombogenicity
100%
Pandora's Box
100%
Ethnic Differences
100%
Vulnerable Blood
40%
Antithrombotic Therapy
40%
Atherothrombotic Event
40%
Clinical Outcomes
20%
Bleeding Risk
20%
Clinical Efficacy
20%
Clinical High Risk
20%
Complex Interactions
20%
Caucasian Patients
20%
Non-ischemic
20%
Fibrinolytic Factors
20%
Complex Interplay
20%
East Asia
20%
Clinical Manifestations
20%
Anticoagulant Factor
20%
Procoagulant Factor
20%
Blood Stasis
20%
African American
20%
Plasma Factors
20%
Component Factor
20%
Cellular Components
20%
East Asian Patients
20%
Atherosclerotic Cardiovascular Disease (ASCVD)
20%
Inflammatory Factors
20%
Racial Differences
20%
Blood Thrombogenicity
20%
Clinical Safety
20%
Atheroma
20%
Medicine and Dentistry
Cardiovascular Disease
100%
Thrombogenicity
100%
Antithrombotic Therapy
16%
Blood Clotting Inhibitor
16%
Race Difference
16%
Antithrombotic
16%
Plasma Factor
16%
Blood Stasis
16%
Fibrinolytic Factor
16%
Procoagulant
16%
Pharmacology, Toxicology and Pharmaceutical Science
Thrombogenicity
100%
Cardiovascular Disease
100%
Fibrinolytic Factor
16%
Blood Stasis
16%
Procoagulant
16%
Antithrombotic Therapy
16%
Anticoagulant Agent
16%
Blood Clotting Inhibitor
16%
Coronary Artery Atherosclerosis
16%